Search

everythinglearnresearchcommunity

for

Search:↓

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Hormonal therapies are safe and effective for treating adult women's acne.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

Skin symptoms often reveal hormonal imbalances in PCOS.

Obesity is linked to more severe lower urinary tract symptoms.

Kidney stones form due to factors like urine concentration, calcium deposits, hormones, gut bacteria, and immune response.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Bariatric surgery is safe and effective for treating adolescent obesity.

THA is a rare condition with no significant clinical consequences if thyroid function is normal.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Crohn's disease can cause hair loss before other symptoms appear.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.